NCT02481960View on ClinicalTrials.gov

Study of Intraparenchymal Therapy With Irinotecan Drug Eluting Beads as Adjunct to Recurrent Surgically Resectable High Grade Glioma

PHASE1/PHASE2TerminatedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

February 21, 2012

Primary Completion Date

December 18, 2015

Study Completion Date

December 18, 2015

Conditions
Glioma
Interventions
PROCEDURE

CM-BC2 Irinotecan drug-eluting bead

Trial Locations (2)

30167

Prof. Erol Sandalcioglu, Hanover

49933

Centre Hopsitalier Universitaire d'Angers, Angers

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY